samsungbiologics.com Open in urlscan Pro
45.60.199.106  Public Scan

Submitted URL: http://www.samsungbiologics.com/
Effective URL: https://samsungbiologics.com/
Submission: On September 15 via api from US — Scanned from DE

Form analysis 4 forms found in the DOM

Name: gSchFrmGET

<form id="gSchFrm" name="gSchFrm" method="get" onsubmit="return gfn_search();">
  <div class="searchField">
    <div class="pix-in">
      <h2 class="tit"><span>Search</span></h2>
      <ul class="form">
        <li class="txt">
          <label for="gSchString">
            <span class="hidden">type in your search word</span>
            <!-- <input type="text" id="gSchString" name="schString" placeholder="Type in your search word"> -->
            <input type="text" id="gSchString" name="schString">
          </label>
        </li>
        <li class="btn"><input type="submit" title="Search"></li>
      </ul>
      <dl class="txt">
        <dt><a href="#">Search suggestions</a></dt>
        <dd>
          <a href="/search?schString=Development">Development</a>
          <a href="/search?schString=Manufacturing">Manufacturing</a>
          <a href="/search?schString=Research">Research</a>
        </dd>
      </dl>
    </div>
  </div>
</form>

Name: hFrmPOST

<form id="hFrm" name="hFrm" method="post">
  <input type="hidden" name="language">
  <input type="hidden" name="schString" value="">
  <input type="hidden" name="searchCd" value="">
</form>

#

<form action="#" id="layer_user_mail_frm" enctype="application/x-www-form-urlencoded">
  <fieldset>
    <legend>뉴스레터 구독 서비스 유무 확인</legend>
    <div class="mailForm">
      <ul>
        <li class="input">
          <label for="layer-user-mail">
            <input type="email" name="user-mail" id="layer-user-mail" value="" placeholder="Enter your email address">
          </label>
        </li>
        <li class="btn">
          <input type="submit" value="확인" title="전송" class="last">
        </li>
      </ul>
    </div>
  </fieldset>
</form>

Name: frm_subscribePOST #

<form id="frm_subscribe" name="frm_subscribe" method="post" action="#">
  <input type="hidden" id="lang" name="lang" value="en">
  <input type="hidden" id="scodelist" name="scodelist">
  <fieldset>
    <legend>Subscribe to Our Newsletter</legend>
    <ul class="field-list">
      <li>
        <dl>
          <dt><label for="layerFromEmail">E-mail</label></dt>
          <dd><input type="text" id="layerFromEmail" name="layerFromEmail"></dd>
        </dl>
      </li>
      <li>
        <dl>
          <dt><label for="layerSubscribeCompany">Company</label></dt>
          <dd><input type="text" id="layerSubscribeCompany" name="layerSubscribeCompany"></dd>
        </dl>
      </li>
      <li>
        <dl>
          <dt><label for="layerSubscribeName">Name</label></dt>
          <dd><input type="text" id="layerSubscribeName" name="layerSubscribeName"></dd>
        </dl>
      </li>
      <li>
        <dl>
          <dt><label for="layerSubscribeJobtitle">Job Title</label></dt>
          <dd><input type="text" id="layerSubscribeJobtitle" name="layerSubscribeJobtitle"></dd>
        </dl>
      </li>
      <li>
        <dl>
          <dt><label for="user-country">Country</label></dt>
          <dd>
            <select name="user-country" id="user-country">
              <option>Search Country</option>
            </select>
          </dd>
        </dl>
      </li>
      <li class="space-typ1">
        <dl>
          <dt><label for="user-interest">Interests</label></dt>
          <dd>
            <ul class="checkbox-list" id="interestListUl">
              <li>
                <span class="checkbox">
                  <input type="checkbox" id="user-all">
                  <label for="user-all">All</label>
                </span>
              </li>
            </ul>
          </dd>
        </dl>
      </li>
      <li class="space-typ2">
        <div class="policy">
          <span class="checkbox">
            <input type="checkbox" id="layerPolicy">
            <label for="layerPolicy"> I agree to the </label>
            <a href="/privacy-policy" target="_blank" title="Window Open">Privacy Policy</a> to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing
            service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers. </span>
        </div>
      </li>
    </ul>
    <div class="btn-submit">
      <input type="submit" value="SUBSCRIBE" id="btn_subscribe" class="last">
    </div>
  </fieldset>
</form>

Text Content

Skip Content


SAMSUNG BIOLOGICS

 * About Us
    * Company
      * About Samsung Biologics
      * Fact Sheet
      * Milestones
   
    * Leadership
      * Key Executives
      * CEO Message
   
    * Location
      * Headquarters
      * Samsung Biologics America
   
    * Virtual Tour
   
    * Useful Pages
      * COVID-19 Resources
      * Virtual Exhibition Hall
      * Plant 4 Showroom

 * Our Services
    * Development Services
      * Overview
      * Service Scope
      * Cell Line Development
      * Process Development
      * Performance
      * Clinical Manufacturing
   
    * Manufacturing Services
      * Overview
      * Drug Substance
        * - Mammalian
        * - mRNA
          
      * Drug Product
   
    * Bioanalytical Testing Services
      * Overview
      * Biosafety Testing Services
      * Analytical Testing Services
   
    * Quality
      * Overview
      * Quality Assurance
      * Quality Control

 * Careers
    * Meet Our People
   
    * What We Value
   
    * Working With Us
      * Career Development
      * Benefits
      * Diversity & Inclusion
   
    * How to Apply
      * How to Apply
      * OverseasExperienced
      * LocalExperienced
      * NewHiresULevel
      * NewHiresCLevel
      * Intern
      * FAQs
   
    * Jobs

 * Sustainability
    * ESG Management
   
    * Environmental
      * Climate Actions
      * ESH Management
      * Environment
      * Safety
      * Health
   
    * Social
      * Human Rights
      * Compliance
      * Business Ethics
      * Corporate Social Responsibility
      * BCMS
   
    * Governance
      * Articles of Incorporation
      * Board Structure
      * BOD Committees
        
      * Corporate Governance
      * External Auditor

 * Investor Relations
    * Overview
   
    * Financial Information
      * Financial Snapshot
      * Public Disclosures
      * Audited
        Financial Statements
      * Annual/Business Report
      * Earnings Release
   
    * Stock & Shareholder
      Information
      * Listing Information
      * Stock Charts
      * Ownership Structure
      * General Meeting of Shareholders
   
    * IR Resource
      * IR Notice
        

 * Newsroom
    * Newsroom
   
    * Company News
      * Press Release
      * News Brief
      * Media Focus
   
    * Our Story
      * Life @ Samsung Biologics
      * Samsung Bio Insight
   
    * Science & Technology
      * Whitepapers
      * Webinars
      * Videos
   
    * Events
   
    * PR Materials
      * Brochures & Infographics
      * Company Images

 * CLIENT PORTAL

search
Korean language site
NEWSFEED
Contact Us
Client Portal
mobile menu button


SEARCH

 * type in your search word
 * 

Search suggestions Development Manufacturing Research


 * Better
   Life with
   Samsung
   Biologics
   
   Enriching human life with
   
   technology and innovation
   
   Better Life
   
   Enriching human
   
   life with technology
   
   and innovation

 * Driven.
   For Life.
   
   It’s in our DNA -
   
   it’s a part of who we are.


stop
Hide

What's New

 * Our Story
   
   Driven. For Security.

 * Our Story
   
   What’s in a Vial? An In-Depth Look into Drug Product Manufacturing

 * Company News
   
   BioProcess Insider Interview: James Park, Chief Business Officer

 * Company News
   
   Samsung Biologics, C&T invest in US biotech firm Senda Biosciences

 * Company News
   
   Frost & Sullivan Institute Recognizes Samsung Biologics with the 2022 Global
   Enlightened Growth Leadership Award for its Commitment to Sustainable Growth

 * Company News
   
   Achieving Faster Investigational New Drug Timelines with a Robust Cell Line
   Development Strategy


stop Go To Newsroom Subscribe Now
Scroll Swipe

Driven. For Security.

Large-Scale Continuous Biomanufacturing: Utilizing N-1 Technology for Higher
Productivity and Quality

What’s in a Vial? An In-Depth Look into Drug Product Manufacturing

Addressing and Adapting to Evolving mRNA Market Trends

Expert Insight | Strategies for a Sustainable Future - Interview with John Rim,
CEO and President of Samsung Biologics

Fundamental Considerations for Bispecific Antibody-based Cell Line Development

Unlocking the Possibilities to the Future of Biopharma | 2022 BIO International
Convention

Driven. For Climate Action.

The Power of One I Samsung Biologics’ mRNA Capabilities


stop

Upcoming Events

   

 * BPI (BioProcess International)
   
   Date : 2022-09-27 ~ 2022-09-30 Venue : Boston

 * CPhI Worldwide
   
   Date : 2022-11-01 ~ 2022-11-03 Venue : Frankfurt, Germany

 * Biomanufacturing World Summit (BMWS)
   
   Date : 2022-11-14 ~ 2022-11-15 Venue : San Diego, US
   

More

Company News

 * [Media Focus] BioProcess Insider Interview: James Park, Chief Business
   Officer
 * [Media Focus] Samsung Biologics, C&T invest in US biotech firm Senda
   Biosciences
 * [Media Focus] Frost & Sullivan Institute Recognizes Samsung Biologics with
   the 2022 Global Enlightened Growth Leadership Award for its Commitment to
   Sustainable Growth
 * [Media Focus] Achieving Faster Investigational New Drug Timelines with a
   Robust Cell Line Development Strategy

More
Go to Newsroom
Swipe
Instargram facebook
Linkedin Follow
Aug 16, 2022
Since the advent of COVID-19, the pharmaceutical industry in particular has had
to rapidly overcome supply chain challenges concurrent with heightened demand.
David King, our Director of Drug Product Operations, discusse...
Aug 11, 2022
In our next decade of growth, our second Bio Campus in Songdo will be built with
top-of-the-line innovation in mind. Through continuous investments, we will
strive to be the most flexible CDMO partner, fully equipped wit...
Aug 10, 2022
We’d like to extend our sincere appreciation to the Frost & Sullivan Institute
for presenting us with the esteemed 2022 Enlightened Growth Leadership Award. As
a sustainable CDMO partner, we are committed to making a hea...

Youtube Subscribe

Samsung Biologics’ mRNA Services | mRNA is revolutionizing the way we prevent,
treat, and possibly cure diseases. With our fully integrated process
development, process characterization, and analytical testing solutions for mRNA
GMP manufacturing, we can help steer your innovative therapeutic successfully
through the clinical and commercial stages.

2022-05-26

San Francisco R&D Center: Your Next-Door CDMO Partner | Our San Francisco R&D
Center brings our trusted cell line development services and technologies closer
to you to serve your needs. Using our expertise and innovation, we can help you
maximize your opportunity to get your molecule to market and patients, faster
and better.

2022-04-20

J.P. Morgan Healthcare Conference Recap | If you missed our presentation at the
@JPMorgan Healthcare Conference, watch CEO John Rim’s quick interview where we
break down the highlights and our key growth drivers for 2022, which include
expanded manufacturing capacity, continued advancements in business portfolio,
and greater global footprint.

2022-01-19


Swipe

Samsung Biologics

Virtual Exhibition Hall

Go to Virtual Hall

Samsung Biologics

Plant4 Showroom

Go to Showroom
 * Our Services
 * Featured Contents
 * Our Posts
 * Useful Pages

 * Site Map
   
 * Privacy Policy
 * Cookie Policy
 * Business Ethics
 * Security Report

   
 * linkedin
 * instagram
 * facebook
 * youtube

Copyright Samsung Biologics. All rights reserved

 * Best Family-Friendly Management
 * WA
 * KOREA AEO


SITE MAP

close
 * ABOUT US
   * Company
     * About Samsung Biologics
     * Fact Sheet
     * Milestones
     
   * Leadership
     * Key Executives
     * CEO Message
   * Location
     * Headquarters
     * Samsung Biologics America
   * Virtual Tour
   * Useful Pages
     * COVID-19 Resources
     * Virtual Exhibition Hall
     * Plant 4 Showroom
 * OUR SERVICES
   * Development Services
     * Overview
     * Service Scope
     * Cell Line Development
     * Process Development
     * Performance
     * Clinical Manufacturing
   * Manufacturing Services
     * Overview
     * Drug Substance
         
       * Mammalian
       * mRNA
         
         
     * Drug Product
   * Bioanalytical Testing Services
     * Overview
     * Biosafety Testing Services
     * Analytical Testing Services
   * Quality
     * Overview
     * Quality Assurance
     * Quality Control
 * CAREERS
   * Meet Our People
   * What We Value
   * Working With Us
     * Career Development
     * Benefits
     * Diversity & Inclusion
   * How to Apply
     * How to Apply
     * FAQs
     
   * Jobs

 * Sustainability
   * ESG Management
   * Environmental
     * Climate Actions
     * ESH Management
     * Environment
     * Safety
     * Health
   * Social
     * Human Rights
     * Compliance
     * Business Ethics
     * Corporate Social Responsibility
     * BCMS
   * Governance
     * Articles of Incorporation
     * Board Structure
     * BOD Committees
     * Corporate Governance
     * External Auditor
 * INVESTOR
   RELATIONS
   * Overview
   * Financial Information
     * Financial Snapshot
     * Public Disclosures
     * Audited
       Financial Statements
     * Annual/Business Report
     * Earnings Release
   * Stock & Shareholder
     Information
     * Listing Information
     * Stock Charts
     * Ownership Structure
     * General Meeting of Shareholders
     
   * IR Resource
     * IR Notice
       
 * Newsroom
   * Newsroom
   * Company News
     * Press Release
     * News Brief
     * Media Focus
   * Our Story
     * Life @ Samsung Biologics
     * Samsung Bio Insight
   * Science & Technology
     * Whitepapers
     * Webinars
     * Videos
   * Events
   * PR Materials
     * Brochures & Infographics
     * Company Images
     

 * CONTACT US

Close


YOUR DOWNLOAD IS READY

Click Download.

Download
Close


SUBSCRIBE TO OUR NEWSLETTER

Subscribe to our newsletter to download.
*If you have already subscribed, enter your email.

뉴스레터 구독 서비스 유무 확인
 * 
 * 

Close


SUBSCRIBE TO OUR NEWSLETTER

Please fill in your details, select one or more areas of interest, and click the
subscribe button to receive our newsletter.

Subscribe to Our Newsletter
 * E-mail
 * Company
 * Name
 * Job Title
 * Country Search Country
 * Interests
    * All

 * I agree to the Privacy Policy to collect the email address that I have
   provided until I withdraw my consent. The collected information will only be
   used for the purpose of mailing service. If you do not wish to consent, you
   will not be able to receive the newsletter. Samsung Biologics respects the
   privacy of its subscribers.


close


COOKIE POLICY

초점받기 링크
Effective date: [22July2019]

This Cookie Policy applies to the Samsung Biologics website (the “Website”).
Please read this Cookie Policy carefully and feel free to contact us if you have
any questions.

What are cookies?

A cookie is a small text file that a website saves on your computer or mobile
device when you visit the Website. It enables the Website to remember your
actions and preferences (such as language preferences) over a period of time, so
you don't have to keep re-entering them whenever you come back to the Website or
browse from one page to another.

How do we use cookies?

This Website uses cookies to understand how you use the Website, provide certain
functionalities on the Website and remember your preferences on the Website. We
retain the information we collect through cookies for up to [26 months] after
collection.

Cookies used on the Website
 * A full list of the cookies that we use on the Website can be found below.
   
   Cookies used on the Website items include Cookie, Name of cookie, Purpose of
   cookie. Cookie Name of cookie Purpose of cookie Google Analytics
   Google Tag Manager _ga
   _gid
   _dc_gtm_<property-id>
   AMP_TOKEN
   _gac_<property-id> These cookies are used to collect information about how
   visitors use our website. We use the information to compile reports and to
   help us improve the website. The cookies collect information in an anonymous
   form, including the number of visitors to the website, where visitors have
   come to the website from and the pages they visited.

How to control cookies

You can control and/or delete cookies as you wish - for details, see
http://www.aboutcookies.org. You can delete all cookies that are already on your
computer and you can set most browsers to prevent them from being placed. If you
do this, however, you may have to manually adjust some preferences every time
you visit a site and some services and functionalities may not work. To opt out
of being tracked by Google Analytics across all websites, visit
https://tools.google.com/dlpage/gaoptout.

close


SECURITY REPORT

Your valuable comments contribute to protecting Samsung Biologic’s core
technology and management information, as well as reinforcing domestic
competency and economic development.

 * This page is created for reporting core technology and management information
   leakage.
 * The reported contents as well as the identity of the reporter are strictly
   secured.

THE MANUAL FOR SECURITY NOTIFICATION
E-mail sbl.infosec@samsung.com
SAMSUNG BIOLOGICS News Room
close


COMPANY NEWS

more
Media Focus

Samsung Biologics Confirms 'No Impact' of COVID-19 with Business Continuity Plan
in Effect

February 25, 2020
Media Focus

Samsung

February 25, 2020

pause




 * BUSINESS & LIFE
   
   -Samsung Biologics and STCube Enter into Development and Manufacturing
   Agreement for Novel Target Anticancer Drug
   
   more


 * SCIENCE & TECHNOLOGY
   
   -Naming Biopharmaceutical Products 1 Monoclonal Antibody Drugs
   
   more


 * UPCOMING EVENTS
   
   -Naming Biopharmaceutical Products 1 Monoclonal Antibody Drugs
   
   more


 * MEDIA FOCUS
   
   -Samsung Biologics and STCube Enter into Development and Manufacturing
   Agreement for Novel Target Agreement for Novel Target
   
   more


 * VIDEOS
   
   -Samsung Biologics and STCube Enter into Development and Manufacturing
   Agreement for Novel Target
   
   more
 * * # Company News
   * # Media Focus
   * # PR Materials
   * # Upcoming Event
   * # Resource Library
   * # IR Notice

Copyright Samsung Biologics. All rights reserved